Effects of diltiazem or verapamil on calcium uptake and release from chicken skeletal muscle sarcoplasmic reticulum

Canadian Journal of Physiology and Pharmacology

Volumn 83, Issue 11, 2005, Pages 967-975

  Paydar, Mehrak Javadi ^a   Pousti, Abbas ^a   Farsam, Hasan ^b   Amanlou, Massoud ^b   Mehr, Shahram Ejtemaei ^a   Dehpour, Ahmad Reza ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Calcium; Chicken; Diltiazem; Sarcoplasmic reticulum; Skeletal muscle; Verapamil

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); CALCIUM; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM CHLORIDE; DILTIAZEM; SILVER; SILVER NITRATE; VERAPAMIL;

ANIMAL EXPERIMENT; BINDING SITE; CALCIUM TRANSPORT; CHICKEN; CONFERENCE PAPER; CONTROLLED STUDY; DATA ANALYSIS; ENZYME ACTIVITY; ENZYME INHIBITION; FLUORESCENCE; IC 50; MICROSOME; NONHUMAN; PRIORITY JOURNAL; SARCOPLASMIC RETICULUM; SKELETAL MUSCLE;

ANIMALS; CALCIUM; CALCIUM CHANNEL BLOCKERS; CALCIUM-TRANSPORTING ATPASES; CHICKENS; DILTIAZEM; MICROSOMES; MUSCLE, SKELETAL; SARCOPLASMIC RETICULUM; SILVER NITRATE; VERAPAMIL;

EID: 33644906938     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/y05-062     Document Type: Conference Paper

References (45)

1. Abramson, J.J., Milne, S., Buck, E., and Pessah, I.N. 1993. Porphyrin induced calcium release from skeletal muscle sarcoplasmic reticulum. Arch. Biochem. Biophys. 301(2): 396-403.
2. 2+ uptake and membrane potential in sarcoplasmic reticulum vesicles. J. Biol. Chem. 255(19): 9156-9161.
3. Bikhazi, G.B., Leung, I., and Foldes, F.F. 1982. Interaction of neuromuscular blocking agents with calcium channel blockers. Anesthesiology, 57: 268.
4. Bikhazi, G.B., Leung, I., and Foldes, F.F. 1983. Calcium channel blockers increase potency of neuromuscular blocking agents in vivo. Anesthesiology, 59: 269.
5. Catterall, W.A., Striessnig, J., Snutch, T.P., and Perez-Reyes, E. 2003. International union of pharmacology. XL. Compendium of voltage-gated ion channels: calcium channels. Pharmacol. Rev. 55(4): 579-581.
6. Chattopadhyay, R.N., Roy, R.K., Das, A.K., Chaudhuri, S., Lahiri, H.L., Maiti, S.P., et al. 1992. Comparative studies of the effects of calcium channel blockers on isolated skeletal muscle preparation. Indian J. Pharmacol. 24: 233-234.
7. Colvin, R.A., Pearson, N., Messineo, F.C., and Katz, A.M. 1982. Effects of Ca channel blockers on Ca transport and Ca ATPase in skeletal and cardiac sarcoplasmic reticulum vesicles. J. Cardiovasc. Pharmacol. 4(6): 935-941.
8. Dehpour, A.R., Mousavizadeh, K., and Gerayesh-Nejad, S. 1998. Calcium release by diltiazem from isolated sarcoplasmic reticulum of rabbit skeletal muscle. Gen. Pharmacol. 31(3): 463-468.
9. Dulhunty, A.F., Junankar, P.R., Eager, K.R., Ahern, G.P., and Laver, D.R. 1996. Ion channels in the sarcoplasmic reticulum of striated muscle. Acta Physiol. Scand. 156 (3): 375-385.
10. Eisenberg, R.S., McCarthy, R.T., and Milton, R.L. 1983. Paralysis of frog skeletal muscle fibres by the calcium antagonist D600. J. Physiol. (Cambridge, U.K.), 341: 495-505.
11. Fernandez-Belda, F., and Gomez-Fernandez, J.C. 1987. Effect of the calcium-channel blockers on calcium accumulation in sarcoplasmic reticulum of skeletal muscle. Biochim. Biophys. Acta, 903(3): 473-479.
12. Fill, M., and Copello, J.A. 2002. Ryanodine receptor calcium release channels. Physiol. Rev. 82 (4): 893-922.
13. Flucher, B.E., Conti, A., Takeshima, H., and Sorrentino, V. 1999. Type 3 and type 1 ryanodine receptors are localized in triads of the same mammalian skeletal muscle fibers. J. Cell. Biol. 146 (3): 621-630.
14. Foster, P.S., and Denborough, M.A. 1989. Effect of diltiazem and dantrolene on the contractility of isolated malignant hyperpyrexia-susceptible porcine skeletal muscle. Br. J. Anaesth. 62(5): 566-572.
15. 2+ channel inhibitors d-cis-diltiazem, (±) bepridil and (-) desmethoxyverapamil to their receptor site in skeletal muscle transverse tubule membranes. Biochem. Biophys. Res. Commun. 132(1): 49-55.
16. 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 260(6): 3440-3450.
17. 2+ release/re-uptake of sarcoplasmic reticulum. Biochem. Biophys. Res. Commun. 279(3): 858-863.
18. 2+ release by the sarcoplasmic reticulum of skeletal muscle cells. Exp. Biol. Med. (Maywood). 227(6): 425-431.
19. Kim, D.H., Ohnishi, S.T., and Ikemoto, N. 1983. Kinetic studies of calcium release from sarcoplasmic reticulum in vitro. J. Biol. Chem. 258(16): 9662-9668.
20. Lai, F.A., Erickson, H.P., Rousseau, E., Liu, Q.Y., and Meissner, G. 1988. Purification and reconstitution of the calcium release channel from skeletal muscle. Nature (London), 331(6154): 315-319.
21. Lorenzon, N.M., Grabner, M., Suda, N., and Beam, K.G. 2001. Structure and targeting of RyR1: implications from fusion of green fluorescent protein at the amino-terminal. Arch. Biochem. Biophys. 388(1): 13-17.
22. Lowry, O.H., Rosebrough, N.J., Farr, A.L., and Randall, R.J. 1951. Protein measurement with the folin phenol reagent. J. Biol. Chem. 193(1): 265-275.
23. Martonosi, A. 1968. Sarcoplasmic reticulum. IV. Solubilization of microsomal adenosine triphosphatase. J. Biol. Chem. 243(1): 71-81.
24. Martonosi, A.N., and Pikula, S. 2003. The network of calcium regulation in muscle. Acta. Biochim. Pol. 50(1): 1-30.
25. Marty, I., Robert, M., Villaz, M., De Jongh, K., Lai, Y., Catterall, W.A., et al. 1994. Biochemical evidence for a complex involving dihydropyridine receptor and ryanodine receptor in triad junctions of skeletal muscle. Proc. Natl. Acad. Sci. U.S.A. 91(6): 2270-2274.
26. Orlowski, S., Mir, L.M., Belehradek, J., Jr., and Garrigos, M. 1996. Effects of steroids and verapamil on P-glycoprotein ATPase activity: progesterone, desoxycorticosterone, corticosterone and verapamil mutually non-exclusive modulators. Biochem. J. 317: 515-522.
27. Ottini, L., Marziali, G., Conti, A., Charlesworth, A., and Sorrentino, V. 1996. α and β isoforms of ryanodine receptor from chicken skeletal muscle are the homologues of mammalian RyR1 and RyR3. Biochem. J. 315: 207-216.
28. 2+ release channel. J. Biol. Chem. 262(13): 6142-6148.
29. Pang, D.C., and Sperelakis, N. 1984. Uptake of calcium antagonistic drugs into muscles as related to their lipid solubilities. Biochem. Pharmacol. 33(5): 821-826.
30. Ruell, P.A., Booth, J., McKenna, M.J., and Sutton, J.R. 1995. Measurement of sarcoplasmic reticulum function in mammalian skeletal muscle: technical aspects. Anal. Biochem. 228(2): 194-201.
31. 2+-ATPase activity in muscle homogenates. Anal. Biochem. 191(2): 321-331.
32. 2+-release channels of skeletal sarcoplasmic reticulum vesicles reconstituted in lipid bilayers. Arch. Biochem. Biophys. 308(1): 214-221.
33. Toffaletti, J.G. 1996. Electrolytes. In Clinical chemistry principles, procedures, correlations. Lippincott, Philadelphia, New York. pp. 271-272.
34. Trimm, J.L., Salama, G., and Abramson, J.J. 1986. Sulfhydryl oxidation induces rapid calcium release from sarcoplasmic reticulum vesicles. J. Biol. Chem. 261(34): 16 092-16 098.
35. 2+ pump. J. Appl. Physiol. 92(4): 1603-1610.
36. Valdivia, H.H., Valdivia, C., Ma, J., and Coronado, R. 1990. Direct binding of verapamil to the ryanodine receptor channel of sarcoplasmic reticulum. Biophys. J. 58(2): 471-481.
37. Warmington, S.A., Hargreaves, M., and Williams, D.A. 1996. A method for measuring sarcoplasmic reticulum calcium uptake in the skeletal muscle using fura-2. Cell. Calcium. 20(1): 73-82.
38. Williams, D.A., and Fay, F.S. 1990. Intracellular calibration of the fluorescent calcium indicator Fura-2. Cell. Calcium, 11(2-3): 75-83.
39. Williams, J.P., Broadbent, M.P., Pearce, A.C., and Jones, R.M. 1983. Verapamil potentiates the neuromuscular blocking effects of enflurane in vitro. Anesthesiology, 59: 276.
40. Wingertzahn, M.A., and Ochs, R.S. 1998. Control of calcium in skeletal muscle ECC: implications for malignant hyperthermia. Mol. Genet. Metab. 65(2): 113-120.
41. Wingertzahn, M.A., and Ochs, R.S. 2001. Changes in ryanodine receptor-mediated calcium release during skeletal muscle differentiation. II. Resolution of a caffeine-ryanodine paradox. Exp. Biol. Med. (Maywood). 226(2): 119-126.
42. Yamaguchi, N., and Kasai, M. 1997. Potentiation of depolarization-induced calcium release from skeletal muscle triads by cyclic ADP-ribose and inositol 1,4,5-triphosphate. Biochem. Biophys. Res. Commun. 240(3): 772-777.
43. Zucchi, R. 1996. Effect of gallopamil on excitation-contraction coupling. Gen. Pharmacol. 27(5): 749-753.
44. 2+ channel/ryanodine receptor: modulation by endogenous effectors, drugs and disease states. Pharmacol. Rev. 49(1): 1-51.
45. Zucchi, R., Limbruno, U., Ronca-Testoni, S., Yu, G., Galbani, P., Ronca, G., et al. 1992. Effects of verapamil, gallopamil, diltiazem and nifedipine on sarcoplasmic reticulum function in rat heart. Cardioscience, 3(3): 167-172.